Literature DB >> 1649978

The spectrum of Jansky-Bielschowsky disease.

P Santavuori1, J Rapola, A Nuutila, R Raininko, M Lappi, J Launes, R Herva, K Sainio.   

Abstract

A series of five patients with a variant type of Jansky-Bielschowsky disease is presented. The disease initiated between four and a half and seven years with mental and slight motor symptoms. The additional neurological symptoms and signs, i.e. visual failure, retinal degeneration, ataxia, myclonia and epilepsy developed in all children before the age of ten years. The present series differs from our previous series of 16 cases especially in regard of neurophysiological findings (photic spikes, high visual evoked potential, VEP and high somatosensory evoked potential, SEP). VEP became abnormally high between 8.0 and 9.5 years instead of being an early finding as in the previous series. Photic spikes appeared also later in the present series. Electromicroscopic investigation revealed cytosomes with fingerprint profiles (FP) in the autonomic ganglion cells and cytosomes with both FP and curvilinear (CP) profiles in many extraneural cells including smooth muscle, Schwann cells, capillary endothelium and macrophages. In the light of our 21 Finnish patients and the literature, the spectrum of Jansky-Bielschowsky disease seems to be much wider than previously assumed. The diagnosis should be based on clinical, ophthalmological, neurophysiological and ultrastructural findings. Repeated neurophysiological studies may be necessary.

Entities:  

Mesh:

Year:  1991        PMID: 1649978     DOI: 10.1055/s-2008-1071423

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  20 in total

Review 1.  Neuronal ceroid lipofuscinoses: a review.

Authors:  N Nardocci; F Cardona
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 3.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

4.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population.

Authors:  T Varilo; M Savukoski; R Norio; P Santavuori; L Peltonen; I Järvelä
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

Review 5.  Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992.

Authors:  A Kohlschütter; R M Gardiner; H H Goebel
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.

Authors:  J D Cooper; A Messer; A K Feng; J Chua-Couzens; W C Mobley
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 7.  The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases.

Authors:  M J Bennett; S L Hofmann
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

8.  MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  T Autti; R Raininko; S L Vanhanen; P Santavuori
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

9.  Adult onset lysosomal storage disease in a Tibetan terrier: clinical, morphological and biochemical studies.

Authors:  J Alroy; S H Schelling; J G Thalhammer; S S Raghavan; M R Natowicz; E M Prence; U Orgad
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses.

Authors:  M Savukoski; M Kestilä; R Williams; I Järvelä; J Sharp; J Harris; P Santavuori; M Gardiner; L Peltonen
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.